T1	Eq-Comparison 42 60	≥ 3 and ≤ 18 years
E1	Eq-Comparison:T1 Operator:T50 Value:T51 Operator:T52 Value:T53 Temporal-Unit:T54
T2	Age 64 67	age
E2	Age:T2 Eq-Comparison:E1
T3	Observation 78 96	predicted survival
E3	Observation:T3 Eq-Comparison:E4
T4	Eq-Comparison 107 125	more than 3 months
E4	Eq-Comparison:T4 Operator:T55 Value:T56 Temporal-Unit:T57
T5	Eq-Comparison 174 186	at least one
E5	Eq-Comparison:T5 Operator:T58 Value:T59
T6	Condition 198 204	lesion
E6	Condition:T6 Name:T60 Minimum-Count:E5
T7	Temporal-Connection 211 224	Postoperative
E7	Temporal-Connection:T7 
A1	Temporal-Connection-Type-Value E7 before
T8	Condition 225 243	pathological stage
E8	Condition:T8 
T9	Eq-Comparison 248 259	group II-IV
E9	Eq-Comparison:T9 Value:T63 Operator:T64 Value:T65
T10	Negation 280 283	not
E10	Negation:T10 Negates:E12
T11	Eq-Comparison 284 292	received
E11	Eq-Comparison:T11 Temporal-Period:T66
T12	Procedure 293 305	radiotherapy
E12	Procedure:T12 Name:T67 Temporality:E11
T13	Temporal-Connection 306 312	before
E13	Temporal-Connection:T13 Arg:E12
A2	Temporal-Connection-Type-Value E13 before
T14	And 314 317	and
E14	And:T14 
T15	Assertion 318 328	can accept
E15	Assertion:T15 Asserted:E16 Asserted2:E18
A3	Assertion-Type-Value E15 hypothetical
T16	Procedure 329 341	chemotherapy
E16	Procedure:T16 Name:T68
T17	Or 342 345	and
E17	Or:T17 Arg:E16 Arg2:E18
T18	Procedure 346 364	surgical treatment
E18	Procedure:T18 Name:T69
T19	Negation 371 373	No
E19	Negation:T19 Negates:E21
T20	Other 374 379	other
E20	Other:T20 Is-Other:E21
T21	Procedure 380 398	anticancer therapy
E21	Procedure:T21 Name:T70
T22	Assertion 399 408	should be
E22	Assertion:T22 Asserted:E24
A4	Assertion-Type-Value E22 hypothetical
T23	Temporal-Connection 414 420	during
E23	Temporal-Connection:T23 Arg:E21 Arg2:E24
A5	Temporal-Connection-Type-Value E23 during
T24	Procedure 421 433	radiotherapy
E24	Procedure:T24 Name:T71
T25	Condition 444 455	main organs
E25	Condition:T25 
T26	Procedure 528 553	Blood routine examination
E26	Procedure:T26 Name:T72
T27	Negation 580 582	no
E27	Negation:T27 
T28	Condition 583 600	blood transfusion
E28	Condition:T28 
T29	Eq-Comparison 601 607	within
E29	Eq-Comparison:T29 Operator:T74
T30	Eq-Comparison 618 625	14 days
E30	Eq-Comparison:T30 Value:T75 Temporal-Unit:T76
T31	Eq-Comparison 627 637	A.HB>90g/L
E31	Eq-Comparison:T31 Unit:T77 Unit:T78
T32	Eq-Comparison 648 654	*109/L
E32	Eq-Comparison:T32 
T33	Eq-Comparison 664 670	*109/L
E33	Eq-Comparison:T33 
T34	Criteria-Count 715 733	following criteria
E34	Criteria-Count:T34 
T35	Observation 738 741	BIL
E35	Observation:T35 Name:T98 Eq-Comparison:E36
T36	Eq-Comparison 742 754	< 1.25 times
E36	Eq-Comparison:T36 Operator:T80 Value:T81
T37	Observation 762 773	upper limit
E37	Observation:T37 
T38	Observation 775 778	ULN
E38	Observation:T38 Name:T83
T39	Observation 784 787	ALT
E39	Observation:T39 Name:T84 Eq-Comparison:E42
T40	And 788 791	and
E40	And:T40 Arg:E39 Arg2:E41
T41	Observation 792 795	AST
E41	Observation:T41 Name:T85 Eq-Comparison:E42
T42	Eq-Comparison 796 805	< 2.5 ULN
E42	Eq-Comparison:T42 Operator:T86 Value:T87 Unit:T88
T43	Observation 810 818	Serum Cr
E43	Observation:T43 
T44	Eq-Comparison 819 826	< 1 ULN
E44	Eq-Comparison:T44 Operator:T90 Value:T91 Unit:T92
T45	Observation 828 859	endogenous creatinine clearance
E45	Observation:T45 Name:T93
T46	Eq-Comparison 860 871	> 50 ml/min
E46	Eq-Comparison:T46 Operator:T94 Value:T95 Unit:T96 Temporal-Unit:T97
T47	Encounter 1027 1036	follow-up
E47	Encounter:T47 
T48	Procedure 1064 1073	treatment
E48	Procedure:T48 
T49	Assertion 1074 1077	can
E49	Assertion:T49 
A6	Assertion-Type-Value E49 hypothetical
T50	Eq-Operator 42 43	≥
A7	Eq-Operator-Value T50 GTEQ
T51	Eq-Value 44 45	3
T52	Eq-Operator 50 51	≤
A8	Eq-Operator-Value T52 LTEQ
T53	Eq-Value 52 54	18
T54	Eq-Temporal-Unit 55 60	years
A9	Eq-Temporal-Unit-Value T54 year
T55	Eq-Operator 107 116	more than
A10	Eq-Operator-Value T55 GT
T56	Eq-Value 117 118	3
T57	Eq-Temporal-Unit 119 125	months
A11	Eq-Temporal-Unit-Value T57 month
T58	Eq-Operator 174 182	at least
A12	Eq-Operator-Value T58 GTEQ
T59	Eq-Value 183 186	one
T60	Condition-Name 198 204	lesion
T61	Condition-Name 211 237	Postoperative pathological
T62	Eq-Unit 238 243	stage
T63	Eq-Value 254 256	II
T64	Eq-Operator 256 257	-
A13	Eq-Operator-Value T64 BETWEEN
T65	Eq-Value 257 259	IV
T66	Eq-Temporal-Period 284 292	received
A14	Eq-Temporal-Period-Value T66 past
T67	Procedure-Name 293 305	radiotherapy
T68	Procedure-Name 329 341	chemotherapy
T69	Procedure-Name 346 364	surgical treatment
T70	Procedure-Name 380 398	anticancer therapy
T71	Procedure-Name 421 433	radiotherapy
T72	Procedure-Name 528 553	Blood routine examination
T73	Observation-Name 583 600	blood transfusion
A15	Observation-Type-Value T73 lab
T74	Eq-Operator 601 607	within
A16	Eq-Operator-Value T74 LTEQ
T75	Eq-Value 618 620	14
T76	Eq-Temporal-Unit 621 625	days
A17	Eq-Temporal-Unit-Value T76 day
T77	Eq-Unit 627 635	A.HB>90g
T78	Eq-Unit 636 637	L
T79	Observation-Name 681 698	Biochemical tests
A18	Observation-Type-Value T79 lab
T80	Eq-Operator 742 743	<
A19	Eq-Operator-Value T80 LT
T81	Eq-Value 744 748	1.25
T82	Eq-Unit 755 773	normal upper limit
A20	Eq-Unit-Value T82 ref-range-high
T83	Observation-Name 775 778	ULN
T84	Observation-Name 784 787	ALT
A21	Observation-Type-Value T84 lab
T85	Observation-Name 792 795	AST
A22	Observation-Type-Value T85 lab
T86	Eq-Operator 796 797	<
A23	Eq-Operator-Value T86 LT
T87	Eq-Value 798 801	2.5
T88	Eq-Unit 802 805	ULN
T89	Observation-Name 807 818	C. Serum Cr
A24	Observation-Type-Value T89 lab
T90	Eq-Operator 819 820	<
A25	Eq-Operator-Value T90 LT
T91	Eq-Value 821 822	1
T92	Eq-Unit 823 826	ULN
T93	Observation-Name 828 859	endogenous creatinine clearance
A26	Observation-Type-Value T93 lab
T94	Eq-Operator 860 861	>
A27	Eq-Operator-Value T94 GT
T95	Eq-Value 862 864	50
T96	Eq-Unit 865 867	ml
T97	Eq-Temporal-Unit 868 871	min
A28	Eq-Temporal-Unit-Value T97 minute
T98	Observation-Name 738 741	BIL
A29	Observation-Type-Value T98 lab
